These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 22087826)

  • 1. Flavonoids as acetylcholinesterase inhibitors.
    Uriarte-Pueyo I; Calvo MI
    Curr Med Chem; 2011; 18(34):5289-302. PubMed ID: 22087826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Acetylcholinesterase (AChE): A Potential Therapeutic Target to Treat Alzheimer's Disease.
    Li Y; Zhang XX; Jiang LJ; Yuan L; Cao TT; Li X; Dong L; Li Y; Yin SF
    Chem Biol Drug Des; 2015 Oct; 86(4):776-82. PubMed ID: 25736722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implications of some selected flavonoids towards Alzheimer's disease with the emphasis on cholinesterase inhibition and their bioproduction by metabolic engineering.
    Orhan IE
    Curr Pharm Biotechnol; 2014; 15(4):352-61. PubMed ID: 25312618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galangin, a flavonol derived from Rhizoma Alpiniae Officinarum, inhibits acetylcholinesterase activity in vitro.
    Guo AJ; Xie HQ; Choi RC; Zheng KY; Bi CW; Xu SL; Dong TT; Tsim KW
    Chem Biol Interact; 2010 Sep; 187(1-3):246-8. PubMed ID: 20452337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In silico and in vitro anti-AChE activity investigations of constituents from Mytragyna speciosa for Alzheimer's disease treatment.
    Innok W; Hiranrat A; Chana N; Rungrotmongkol T; Kongsune P
    J Comput Aided Mol Des; 2021 Mar; 35(3):325-336. PubMed ID: 33439402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural products as sources of new lead compounds for the treatment of Alzheimer's disease.
    Huang L; Su T; Li X
    Curr Top Med Chem; 2013; 13(15):1864-78. PubMed ID: 23931437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent Acetylcholinesterase Inhibitors: Potential Drugs for Alzheimer's Disease.
    Akıncıoğlu H; Gülçin İ
    Mini Rev Med Chem; 2020; 20(8):703-715. PubMed ID: 31902355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and evaluation of novel 4-dimethylamine flavonoid derivatives as potential multi-functional anti-Alzheimer agents.
    Luo W; Su YB; Hong C; Tian RG; Su LP; Wang YQ; Li Y; Yue JJ; Wang CJ
    Bioorg Med Chem; 2013 Dec; 21(23):7275-82. PubMed ID: 24148835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of Anti-Alzheimer's Activity of Flavonoids Targeting Acetylcholinesterase in silico.
    Das S; Laskar MA; Sarker SD; Choudhury MD; Choudhury PR; Mitra A; Jamil S; Lathiff SMA; Abdullah SA; Basar N; Nahar L; Talukdar AD
    Phytochem Anal; 2017 Jul; 28(4):324-331. PubMed ID: 28168765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and in vitro evaluation of N-alkyl-7-methoxytacrine hydrochlorides as potential cholinesterase inhibitors in Alzheimer disease.
    Korabecny J; Musilek K; Holas O; Binder J; Zemek F; Marek J; Pohanka M; Opletalova V; Dohnal V; Kuca K
    Bioorg Med Chem Lett; 2010 Oct; 20(20):6093-5. PubMed ID: 20817518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and evaluation of flavonoid derivatives as potential multifunctional acetylcholinesterase inhibitors against Alzheimer's disease.
    Li RS; Wang XB; Hu XJ; Kong LY
    Bioorg Med Chem Lett; 2013 May; 23(9):2636-41. PubMed ID: 23511019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and evaluation of 4-dimethylamine flavonoid derivatives as potential multifunctional anti-Alzheimer agents.
    Luo W; Wang T; Hong C; Yang YC; Chen Y; Cen J; Xie SQ; Wang CJ
    Eur J Med Chem; 2016 Oct; 122():17-26. PubMed ID: 27343850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and acetylcholinesterase inhibitory activity of Mannich base derivatives flavokawain B.
    Liu HR; Huang XQ; Lou DH; Liu XJ; Liu WK; Wang QA
    Bioorg Med Chem Lett; 2014 Oct; 24(19):4749-4753. PubMed ID: 25205193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining in silico and in vitro approaches to evaluate the acetylcholinesterase inhibitory profile of some commercially available flavonoids in the management of Alzheimer's disease.
    Kuppusamy A; Arumugam M; George S
    Int J Biol Macromol; 2017 Feb; 95():199-203. PubMed ID: 27871793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and evaluation of flavonoid derivatives as potent AChE inhibitors.
    Sheng R; Lin X; Zhang J; Chol KS; Huang W; Yang B; He Q; Hu Y
    Bioorg Med Chem; 2009 Sep; 17(18):6692-8. PubMed ID: 19692250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and preliminary structure-activity relationship investigation of nitrogen-containing chalcone derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors: a further study based on Flavokawain B Mannich base derivatives.
    Liu H; Fan H; Gao X; Huang X; Liu X; Liu L; Zhou C; Tang J; Wang Q; Liu W
    J Enzyme Inhib Med Chem; 2016 Aug; 31(4):580-9. PubMed ID: 26186269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular modeling and in vitro approaches towards cholinesterase inhibitory effect of some natural xanthohumol, naringenin, and acyl phloroglucinol derivatives.
    Orhan IE; Jedrejek D; Senol FS; Salmas RE; Durdagi S; Kowalska I; Pecio L; Oleszek W
    Phytomedicine; 2018 Mar; 42():25-33. PubMed ID: 29655693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel tacrine analogs as potential cholinesterase inhibitors in Alzheimer's disease.
    El-Malah A; Gedawy EM; Kassab AE; Salam RM
    Arch Pharm (Weinheim); 2014 Feb; 347(2):96-103. PubMed ID: 24343873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetylcholinesterase inhibitors as Alzheimer therapy: from nerve toxins to neuroprotection.
    Singh M; Kaur M; Kukreja H; Chugh R; Silakari O; Singh D
    Eur J Med Chem; 2013; 70():165-88. PubMed ID: 24148993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flavonoids as acetylcholinesterase inhibitors: Current therapeutic standing and future prospects.
    Khan H; Marya ; Amin S; Kamal MA; Patel S
    Biomed Pharmacother; 2018 May; 101():860-870. PubMed ID: 29635895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.